Haizeng Zhang

Haizeng Zhang

Auto-generated profile, based on publicly available information

Haizeng Zhang

Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Capital Medical University, Beijing, China (Z.C., H.Z., Q.Y., L.F., Q.L., X.G., F.Y., J. Cui, Y.T., J. Cai)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Autophagy
Verified
Journal Article
Closed access
ZCZhenzhen Chen
Zhenzhen Chen
COChenxi Ouyang
Chenxi Ouyang
HZHaizeng Zhang
Haizeng Zhang
YGYuanrui Gu
Yuanrui Gu
YDYue Deng
Yue Deng
BGBin Geng
Bin Geng
Vascular smooth muscle cells (VSMCs) contribute to plaque stability. VSMCs are also a major source of CTH (cystathionine gamma-lyase)-hydrogen sulfide (H2S), a protective gasotransmitter in atherosclerosis. However, the role of VSMC endogenous CTH-H2S in pathogenesis of plaque stability and the mechanism are unknown. In human carotid plaques, CTH expression in ACTA2+ cells was dramatically downregulated in lesion areas in comparison to non-lesion areas. Intraplaque CTH expression was positively correlated with collagen content, whereas there was a negative correlation with CD68+ and necrotic core area, resulting in a rigorous correlation with vulnerability index (r = −0.9033). Deletion of Cth in VSMCs exacerbated plaque vulnerability, and were associated with VSMC autophagy decline, all of which were rescued by H2S donor. In ox-LDL treated VSMCs, cth deletion reduced collagen and heightened apoptosis association with autophagy reduction, and vice versa. For the mechanism, CTH-H2S mediated VSMC autophagosome formation, autolysosome formation and lysosome function, in part by activation of TFEB, a master regulator for autophagy. Interference with TFEB blocked CTH-H2S effects on VSMCs collagen and apoptosis. Next, we demonstrated that CTH-H2S sulfhydrated TFEB at Cys212 site, facilitating its nuclear translocation, and then promoting transcription of its target genes such as ATG9A, LAPTM5 or LDLRAP1. Conclusively, CTH-H2S increases VSMC autophagy by sulfhydration and activation of TFEB, promotes collagen secretion and inhibits apoptosis, thereby attenuating atherogenesis and plaque vulnerability. CTH-H2S may act as a warning biomarker for vulnerable plaque. Abbreviations ATG9A: autophagy related 9A; CTH: cystathionine gamma-lyase; CQ: chloroquine; HASMCs: human aortic smooth muscle cells; H2S: hydrogen sulfide; LAMP1: lysosomal associated membrane protein 1; LAPTM5: lysosomal protein transmembrane 5; NaHS: sodium hydrosulfide hydrate; ox-LDL: oxidized-low density lipoprotein; PPG: DL- propagylglycine; TFEB: transcription factor EB; 3-MA: 3-methyladenine; VSMCs: vascular smooth muscle cells.

15 August 2025 in Circulation Research
Verified
Journal Article
Closed access
ZCZhenzhen Chen
Zhenzhen Chen
HZHaizeng Zhang
Haizeng Zhang
WLWen-Dong Li
Wen-Dong Li
QLQianhui Ling
Qianhui Ling
WCWenwen Cong
Wenwen Cong
JCJun Cai
Jun Cai
BACKGROUND: Hypertension is a prevalent chronic disease worldwide. Elevated hydrostatic pressure (HP) is the main feature of hypertension. GPCRs (G-protein–coupled receptors) are crucial for vascular tone and a significant pharmacological target for drug development. Here, we aimed to identify the key GPCR under high HP, and explore its role and mechanism in hypertension and vascular remodeling. METHODS: First, RNA sequencing (RNA-seq) was performed under high HP and identified the highly expressed GPCR-GPR146. Furthermore, global knockout GPR146 mice, vascular smooth muscle cell (SMC)–specific knockin and knockout GPR146 mice were used to explore its function in hypertension. Next, an HP loading system ex vivo was established to evaluate the role of GPR146 in response to HP. Vascular SMC–specific Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) mice were constructed to investigate the relationship between GPR146 and PIEZO1 . In vitro, GPR146-mediated downstream signaling transduction was detected by proximity ligation assay and bioluminescence resonance energy transfer. Finally, the therapeutic effect of hypertension was detected by GPR146 neutralization antibody injection. RESULTS: Under high HP, we identified a highly expressed GPCR-GPR146 in vascular SMCs by RNA-seq and confirmed it in the arterial media of patients with hypertension and animal models. Functionally, overexpression or deletion of Gpr146 in SMCs demonstrated that GPR146 facilitated vascular contraction, promoted vascular SMCs phenotype switching from a contractile phenotype to synthetic phenotype and proinflammation phenotype, and led to blood pressure elevation, vascular remodeling, and cardiac hypertrophy aggravation. In vitro, GPR146 was upregulated in an HP-dependent manner. Mechanistically, GPR146 is a Gα s -coupled GPCR activating the cAMP-CREB1 (cAMP response element–binding protein 1) signaling cascade. Notably, GPR146 upregulated PIEZO1 expression by enhancing CREB1 binding to the PIEZO1 promoter region. Piezo1 deletion in SMCs blocked Gpr146-induced blood pressure elevation and vascular dysfunction. GPR146 neutralization antibody injection markedly alleviates angiotensin II–induced hypertension and vascular remodeling. CONCLUSIONS: Collectively, GPR146 coupled with Gα s and activating the cAMP-CREB1-PIEZO1 signaling pathway contributes to hypertension and vascular remodeling. Blocking GPR146 is an effective therapeutic strategy for hypertension.

4 June 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYing Zhao
Ying Zhao
CCChangting Cui
Changting Cui
HGHuimin Gao
Huimin Gao
YYYan Yao
Yan Yao
YNYaping Niu
Yaping Niu
BGBin Geng
Bin Geng
Hydrogen sulfide (H₂S), generated by cystathionine γ-lyase (CSE), protects against aortic aneurysm and dissection (AAD), yet its role in extracellular matrix (ECM) regulation remains unclear. Here, we demonstrate that CSE expression is markedly attenuated in vascular smooth muscle cells (VSMCs) from human AAD specimens and AngII-induced male murine models. VSMC-specific Cse deletion exacerbated AAD formation. Mechanistically, Cse deficiency downregulated CBX3, thereby relieving transcriptional repression of Adamts4. Cbx3 overexpression rescued the aggravated AAD phenotype in Cse-deficient male mice. We further identified a CBX3-centered epigenetic complex (SUV39H1, KDM2A, HDAC1, RING1) that coordinates H3K9/4 methylation and acetylation to regulate ECM remodeling, apoptosis and inflammation-related genes. Notably, CSE/H₂S induced CBX3 sulfhydration at C69, C160, and C177, enhancing protein stability by reducing ubiquitin-mediated degradation; Therapeutically, AAV-mediated Cse or Cbx3 delivery via an extravascular carrier attenuated AAD incidence and progression in male mice. Collectively, these findings define a VSMCs CSE/H₂S-CBX3 epigenetic axis that constrains AAD through regulation of the ADAMTS4-versican pathway.

13 October 2026 in Circulation
Verified
Journal Article
Closed access
ZCZhenzhen Chen
Zhenzhen Chen
HZHaizeng Zhang
Haizeng Zhang
QYQiaoxi Yang
Qiaoxi Yang
LFLuyun Fan
Luyun Fan
XDXilan Dong
Xilan Dong
JCJun Cai
Jun Cai
BACKGROUND: Hypertension is a major risk factor for cardiovascular diseases. RNA N6-methyladenosine (m 6 A) modification is closely linked to hypertension pathogenesis, but key m 6 A-related factors that regulate blood pressure remain unclear. This study aims to identify these regulators and evaluate their therapeutic potential. METHODS: We assessed RNA m 6 A changes and METTL (methyltransferase-like) expression in hypertensive aortas via methylated RNA immunoprecipitation sequencing and RNA sequencing (RNA-seq). Global Mettl7b knockout mice and vascular smooth muscle cell (VSMC)–specific Mettl7b knockin and knockout mice were used to evaluate its in vivo role. Downstream target genes were identified via methylated RNA immunoprecipitation sequencing, enhanced cross-linking and immunoprecipitation sequencing, and RNA-seq. METTL7B activators were screened using molecular docking and surface plasmon resonance and validated in vivo via intraperitoneal injection. RESULTS: Under hypertensive stress, METTL7B expression positively correlated with global RNA m 6 A content, exhibiting concurrent depletion in VSMCs. In vitro biochemical assays revealed that recombinant METTL7B significantly increased RNA m 6 A levels. Crucially, METTL7B overexpression in METTL3 knockout cells robustly upregulated m 6 A levels, definitively establishing METTL7B as a novel, METTL3-independent RNA m 6 A methyltransferase. Physiologically, VSMC-specific Mettl7b ablation exacerbated angiotensin II–induced hypertensive pathogenesis, structural arterial remodeling, and vascular tone, whereas its overexpression exerted potent vasoprotective effects. Mechanistically, METTL7B recruited HNRNPH1 to catalyze m 6 A deposition at the 3′ untranslated region of FILIP1L mRNA, facilitating its maturation. Importantly, the expression of FILIP1L was positively correlated with blood pressure reduction in humans and mice. Elevated FILIP1L downregulated the expression of its binding protein FLNA (Filamin A), reducing F-actin polymerization, attenuating VSMC contractility, and ultimately lowering blood pressure. Furthermore, FILIP1L overexpression reversed the detrimental effects of Mettl7b knockout on hypertension and vascular remodeling, whereas these effects were not rescued by the mutation of FILIP1L’s m 6 A site. Elucidating the upstream pathology, we found that stress-induced KLF4 directly bound the METTL7B promoter, transcriptionally repressing its expression. Finally, the Food and Drug Administration–approved drug netarsudil exerted preventive and therapeutic effects on hypertension and vascular remodeling by activating METTL7B; notably, these therapeutic benefits were completely abolished in VSMC-specific Mettl7b knockout mice. CONCLUSIONS: Collectively, our study identifies a novel RNA m 6 A methyltransferase, METTL7B. The METTL7B-HNRNPH1-FILIP1L axis mitigates hypertension by regulating VSMC dedifferentiation and vascular tone. Targeted activation of METTL7B may emerge as a promising strategy for hypertension.